Skip to main content
Aether Industries Limited logo

Aether Industries Limited — Investor Relations & Filings

Ticker · AETHER ISIN · INE0BWX01014 LEI · 335800N7FL6LX9XELD45 BSE.NS Manufacturing
Open in API
Filings indexed 537 across all filing types
Latest filing 2022-07-18 Regulatory Filings
Country IN India
Listing BSE.NS AETHER

About Aether Industries Limited

https://aether.co.in/

Aether Industries Limited focuses on the production of advanced intermediates involving complex and differentiated chemistry. The organization operates through three distinct business models: large-scale manufacturing of proprietary products, contract research and manufacturing services (CRAMS), and contract manufacturing. Its portfolio supports applications in pharmaceuticals, agrochemicals, material science, and high-performance polymers. Aether leverages integrated research and development capabilities, utilizing dedicated R&D centers and pilot plants to scale chemical processes from initial development to commercial volumes. Technical expertise includes specialized chemistries such as Grignard reactions, hydrogenation, and ethylene oxide chemistry. The company provides high-value building blocks and customized manufacturing solutions, emphasizing innovation and process efficiency to meet the requirements of a global client base.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial results
Regulatory Filings Classification · 95% confidence The document is a short notice informing about a scheduled Board Meeting on 25th July 2022 to consider unaudited standalone financial results for the quarter ended 30th June 2022. It is addressed to stock exchanges as per SEBI regulations. The document does not contain any financial data or results itself, but is an announcement of an upcoming board meeting where financial results will be considered. The length is only 1618 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about a board meeting and financial results consideration, not the financial report itself or a detailed management discussion.
2022-07-18 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges reporting the outcome of a meeting with investors. It references compliance with SEBI regulations and confirms that no unpublished price sensitive information was discussed. The document is brief (1649 characters) and serves as an announcement of an event rather than a detailed report or financial statement. It does not contain financial data, audit information, or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-07-09 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short notice titled 'Outcome of Meeting with an Investor' addressed to stock exchanges, referencing a prior intimation and compliance with SEBI regulations. It reports on a virtual meeting with an investor discussing publicly available information and explicitly states no unpublished price sensitive information was shared. The document is brief (1649 characters) and serves as an announcement of an event rather than a detailed report or financial disclosure. It does not contain financial data, management discussion, or regulatory certifications. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-07-08 English
General updates
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate submitted under Section 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the first quarter ended June 30, 2022. It is addressed to stock exchanges and references a certificate from the Registrar and Share Transfer Agent. The document is short (1603 characters) and serves as a regulatory compliance submission rather than a full financial report or detailed filing. It does not contain financial statements or detailed analysis, nor is it an announcement of voting results, management changes, or capital updates. It fits best under Regulatory Filings (RNS) as a compliance certificate submission under SEBI regulations.
2022-07-08 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges about the schedule of an investor meeting. It references Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an intimation of a scheduled meeting with investors, specifying date, type, and mode, and explicitly states no unpublished price sensitive information will be discussed. There are no financial statements, detailed financial data, or report content. The document length is only 1740 characters, indicating it is a brief announcement rather than a full report. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into other specific categories like investor presentations or earnings releases.
2022-07-07 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short communication titled 'Outcome of the Meeting with Analysts' addressed to stock exchanges, referencing a prior intimation and Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It reports on a meeting with analysts discussing publicly available information and explicitly states no unpublished price sensitive information was shared. The document is brief (1664 characters), does not contain financial statements or detailed financial data, and serves as an announcement of the meeting outcome rather than a full report or transcript. It does not fit categories like Call Transcript (CT) because it is not a full transcript, nor Annual Report or Interim Report due to lack of financial data. It is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2022-07-07 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.